Intravenous γ‐Globulin Treatment in Kawasaki Disease

Pediatrics International

Volumn 33, Issue 6, 1991, Pages 805-810

  Harada, Kensuke ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Gamma globulin; Kawasaki disease

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN;

ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PROSPECTIVE STUDY; RANDOMIZATION;

ASPIRIN; CHILD, PRESCHOOL; CORONARY ANEURYSM; DILATATION, PATHOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMAN; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T;

EID: 0026342708     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.1991.tb02612.x     Document Type: Article

References (4)

1. High‐dose intravenous gamma‐globulin for Kawasaki disease
2. The treatment of Kawasaki syndrome with intravenous gamma‐globulin